| N-to C-terminal SNARE complex assembly promotes rapid membrane fusion AV Pobbati, A Stein, D Fasshauer Science 313 (5787), 673-676, 2006 | 378 | 2006 |
| Hippo pathway-independent restriction of TAZ and YAP by angiomotin SW Chan, CJ Lim, YF Chong, AV Pobbati, C Huang, W Hong Journal of Biological Chemistry 286 (9), 7018-7026, 2011 | 377 | 2011 |
| Emerging roles of TEAD transcription factors and its coactivators in cancers AV Pobbati, W Hong Cancer biology & therapy 14 (5), 390-398, 2013 | 229 | 2013 |
| Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24 S Ghazi-Tabatabai, S Saksena, JM Short, AV Pobbati, DB Veprintsev, ... Structure 16 (9), 1345-1356, 2008 | 158 | 2008 |
| Agrin as a mechanotransduction signal regulating YAP through the Hippo pathway S Chakraborty, K Njah, AV Pobbati, YB Lim, A Raju, M Lakshmanan, ... Cell reports 18 (10), 2464-2479, 2017 | 143 | 2017 |
| Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes AV Pobbati, SW Chan, I Lee, H Song, W Hong Structure 20 (7), 1135-1140, 2012 | 131 | 2012 |
| Structural Basis for the Inhibitory Role of Tomosyn in Exocytosis*♦ AV Pobbati, A Razeto, M Böddener, S Becker, D Fasshauer Journal of Biological Chemistry 279 (45), 47192-47200, 2004 | 120 | 2004 |
| Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy AV Pobbati, X Han, AW Hung, S Weiguang, N Huda, GY Chen, CB Kang, ... Structure 23 (11), 2076-2086, 2015 | 112 | 2015 |
| A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy AV Pobbati, W Hong Theranostics 10 (8), 3622, 2020 | 62 | 2020 |
| VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle N Figeac, AD Mohamed, C Sun, M Schönfelder, D Matallanas, ... Journal of cell science 132 (13), jcs225946, 2019 | 36 | 2019 |
| Evolution and assembly of ESCRTs S Ghazi-Tabatabai, T Obita, AV Pobbati, O Perisic, RY Samson, SD Bell, ... Biochemical Society Transactions 37 (1), 151-155, 2009 | 26 | 2009 |
| A role of agrin in maintaining the stability of vascular endothelial growth factor receptor-2 during tumor angiogenesis K Njah, S Chakraborty, B Qiu, S Arumugam, A Raju, AV Pobbati, ... Cell reports 28 (4), 949-965. e7, 2019 | 25 | 2019 |
| Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4 Y Li, S Liu, EY Ng, R Li, A Poulsen, J Hill, AV Pobbati, AW Hung, W Hong, ... Biochemical Journal 475 (12), 2043-2055, 2018 | 25 | 2018 |
| Identification of quinolinols as activators of TEAD-dependent transcription AV Pobbati, T Mejuch, S Chakraborty, H Karatas, SR Bharath, SM Guéret, ... ACS Chemical Biology 14 (12), 2909-2921, 2019 | 17 | 2019 |
| Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex AV Pobbati, BP Rubin Molecules 25 (24), 6001, 2020 | 16 | 2020 |
| A protein tertiary structure mimetic modulator of the Hippo signalling pathway H Adihou, R Gopalakrishnan, T Förster, SM Guéret, R Gasper, ... Nature communications 11 (1), 1-10, 2020 | 15 | 2020 |
| Discovery of covalent inhibitors targeting the transcriptional enhanced associate domain central pocket H Karatas, M Akbarzadeh, H Adihou, G Hahne, AV Pobbati, E Yihui Ng, ... Journal of medicinal chemistry 63 (20), 11972-11989, 2020 | 15 | 2020 |
| WWTR1 (TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis CN Seavey, AV Pobbati, A Hallett, S Ma, JP Reynolds, R Kanai, JM Lamar, ... Genes & development 35 (7-8), 512-527, 2021 | 14 | 2021 |
| Transglutaminase 2 Is a Direct Target Gene of YAP/TAZ CY Liu, AV Pobbati, Z Huang, L Cui, W Hong Cancer Research 77 (17), 4734-4735, 2017 | 7 | 2017 |
| Design, Synthesis and Evaluation of a Series of 1, 5‐Diaryl‐1, 2, 3‐triazole‐4‐carbohydrazones as Inhibitors of the YAP‐TAZ/TEAD Complex F Gibault, M Sturbaut, M Coevoet, M Pugnière, A Burtscher, F Allemand, ... ChemMedChem 16 (18), 2823-2844, 2021 | 5 | 2021 |
